HER2 loss after neoadjuvant treatment: is the adjuvant trastuzumab treatment feasible?—reply

Publication date: Available online 22 April 2017
Source:Human Pathology
Author(s): Zhaoying Xian, Debra L. Zynger




http://ift.tt/2oTrZVQ